Migraines and ADHD in adults

The link between ADHD and migraines is increasingly well documented but still underappreciated in clinical practice. Adults with ADHD have substantially elevated migraine rates compared to the general population, and the two conditions interact in ways that complicate both diagnosis and management. Understanding the neuroscience of this overlap — and practical strategies for managing both — is genuinely useful for the large number of people who experience both.

How Common Is the Overlap?

A 2019 meta-analysis in Cephalalgia found that individuals with ADHD had a pooled odds ratio of 1.8–2.4 for migraine compared to individuals without ADHD, across multiple population-based studies. Among adults with ADHD specifically, migraine prevalence estimates range from 28–35%, compared to approximately 12–15% in the general adult population. The association is present across multiple countries and healthcare systems and does not appear to be driven by shared medication use or other confounders.

Proposed Neurobiological Mechanisms

Several mechanisms have been proposed to explain the ADHD-migraine link, and they are not mutually exclusive. The most researched involves dopaminergic pathways: both ADHD and migraine involve dysregulation of dopamine signalling, with ADHD characterised by reduced dopaminergic tone in prefrontal circuits and migraine associated with altered dopaminergic responsivity in the hypothalamus and brainstem. A 2020 review in Frontiers in Neurology proposed that dopamine hyposensitivity creates a common vulnerability for both conditions.

Serotonergic pathways are also implicated. Triptans — the primary acute treatment for migraine — target serotonin 5-HT1B/D receptors, and serotonergic dysregulation is a feature of both conditions. Additionally, shared genetic risk factors have been identified: variants affecting genes regulating monoaminergic signalling appear in genome-wide association studies for both ADHD and migraine.

A third mechanism involves cortical arousal dysregulation. Both ADHD and migraine are associated with altered cortical excitability — ADHD with underarousal of prefrontal circuits and migraine with periods of cortical hyperexcitability that precipitate the spreading cortical depression underlying aura and headache.

ADHD Medications and Migraine

The relationship between ADHD medication and migraine is complex and requires individual assessment. Stimulant medications (methylphenidate, amphetamine salts) are vasoconstrictive and can worsen migraine in some individuals; they may also temporarily elevate blood pressure, a relevant concern given cardiovascular changes that accompany migraine. However, some patients report that effective ADHD treatment actually reduces their migraine frequency — possibly via improved stress regulation, better sleep hygiene, and reduction in the physiological arousal of chronic ADHD-related stress.

Atomoxetine (Strattera) has a different pharmacological profile and may be worth considering in individuals with comorbid ADHD and migraine who find stimulants worsen headache. Clinical decisions should be made with both conditions in mind, ideally with involvement from both a psychiatrist/neurologist managing ADHD and a neurologist managing migraine.

Practical Management Considerations

Several lifestyle factors affect both ADHD and migraine simultaneously, making them high-leverage targets for management. Sleep dysregulation is a trigger for both conditions — irregular sleep schedules worsen ADHD symptoms and reliably trigger migraines in susceptible individuals. Maintaining consistent sleep and wake times has evidence for both. Dietary regularity matters as well: skipped meals drive blood glucose instability that triggers both migraine (hypoglycaemia) and ADHD symptom worsening (glucose is a key substrate for prefrontal cortex function). Regular aerobic exercise improves dopaminergic signalling, which is relevant to both conditions, and has been shown to reduce migraine frequency in several randomised trials.

Keeping a combined symptom diary — tracking ADHD symptom severity, headache occurrence, sleep, meals, and stress levels — can help identify individual triggers and patterns that inform both medication management and lifestyle adjustments.

For more on the neurological underpinnings of ADHD, see our article on executive dysfunction in ADHD. For information on medication options beyond stimulants, see our guide to bupropion for ADHD.

Dr. Adeel Sarwar, PhD, is a mental health professional specialising in a broad spectrum of psychological conditions such as depression, anxiety, ADHD, eating disorders, and obsessive-compulsive disorder (OCD). Armed with years of experience and extensive training in evidence-based therapeutic practices, Dr. Sarwar is deeply committed to delivering empathetic and highly effective treatment.